Menu
  • Join
  • Login
  • Contact
 

Search abstracts


A novel approach to the preparation and scale up production of pentoxifylline controlled release tablets:ii. bioequivalence study

  • At: 2005 FIP Congress in Cairo (Egypt)
  • Type: Poster
  • By: SHARAF EL DIN, Mohamed Ashraf (Five Fives Co., Quality Departments, Alexandria, Egypt)
  • Co-author(s): Sharaf (A. A. K. Co., CAIRO, Egypt)
    Elkhesen (Fac.of Pharmacy , Cairo univ., CAIRO, Egypt)
    Khattab (Fac. of Pharmacy, Azhar Univ., CAIRO, Egypt)
    Nour (Fac.of Pharmacy , Cairo univ., CAIRO, Egypt)
  • Abstract:

    Aim: The bioequivalence of a single 600-mg doses of pentoxifylline, newly formulated controlled release tablets, (Treatment A) and Trental[RSYMBOL] tablets (Treatment B) were evaluated in a crossover study in 12 healthy volunteers under fasting conditions.

    Experimental: In vitro dissolution profiles were determined for the new formulation and..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses